Guardant Health (GH) Competitors $47.23 -2.30 (-4.64%) As of 04/30/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock GH vs. NTRA, FMS, HIMS, OPCH, RDNT, SHC, WGS, BTSG, PRVA, and CONShould you be buying Guardant Health stock or one of its competitors? The main competitors of Guardant Health include Natera (NTRA), Fresenius Medical Care (FMS), Hims & Hers Health (HIMS), Option Care Health (OPCH), RadNet (RDNT), Sotera Health (SHC), GeneDx (WGS), BrightSpring Health Services (BTSG), Privia Health Group (PRVA), and Concentra Group Holdings Parent (CON). These companies are all part of the "healthcare" industry. Guardant Health vs. Natera Fresenius Medical Care Hims & Hers Health Option Care Health RadNet Sotera Health GeneDx BrightSpring Health Services Privia Health Group Concentra Group Holdings Parent Natera (NASDAQ:NTRA) and Guardant Health (NASDAQ:GH) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, risk, community ranking, valuation, profitability, earnings, institutional ownership, dividends and media sentiment. Which has more risk & volatility, NTRA or GH? Natera has a beta of 1.8, indicating that its stock price is 80% more volatile than the S&P 500. Comparatively, Guardant Health has a beta of 1.45, indicating that its stock price is 45% more volatile than the S&P 500. Do institutionals & insiders have more ownership in NTRA or GH? 99.9% of Natera shares are owned by institutional investors. Comparatively, 92.6% of Guardant Health shares are owned by institutional investors. 7.6% of Natera shares are owned by company insiders. Comparatively, 5.5% of Guardant Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Which has better valuation & earnings, NTRA or GH? Natera has higher revenue and earnings than Guardant Health. Natera is trading at a lower price-to-earnings ratio than Guardant Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNatera$1.70B12.02-$434.80M-$1.53-98.65Guardant Health$739.02M7.89-$479.45M-$3.56-13.27 Is NTRA or GH more profitable? Natera has a net margin of -14.01% compared to Guardant Health's net margin of -59.05%. Natera's return on equity of -26.23% beat Guardant Health's return on equity.Company Net Margins Return on Equity Return on Assets Natera-14.01% -26.23% -14.27% Guardant Health -59.05%-19,157.20%-25.96% Does the MarketBeat Community favor NTRA or GH? Natera received 194 more outperform votes than Guardant Health when rated by MarketBeat users. However, 71.22% of users gave Guardant Health an outperform vote while only 68.96% of users gave Natera an outperform vote. CompanyUnderperformOutperformNateraOutperform Votes49168.96% Underperform Votes22131.04% Guardant HealthOutperform Votes29771.22% Underperform Votes12028.78% Do analysts rate NTRA or GH? Natera presently has a consensus target price of $175.76, suggesting a potential upside of 16.45%. Guardant Health has a consensus target price of $49.00, suggesting a potential upside of 3.75%. Given Natera's higher probable upside, analysts plainly believe Natera is more favorable than Guardant Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Natera 0 Sell rating(s) 0 Hold rating(s) 16 Buy rating(s) 0 Strong Buy rating(s) 3.00Guardant Health 0 Sell rating(s) 0 Hold rating(s) 20 Buy rating(s) 1 Strong Buy rating(s) 3.05 Does the media refer more to NTRA or GH? In the previous week, Natera had 2 more articles in the media than Guardant Health. MarketBeat recorded 29 mentions for Natera and 27 mentions for Guardant Health. Natera's average media sentiment score of 1.10 beat Guardant Health's score of 0.73 indicating that Natera is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Natera 21 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Guardant Health 14 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 2 Very Negative mention(s) Positive SummaryNatera beats Guardant Health on 14 of the 19 factors compared between the two stocks. Get Guardant Health News Delivered to You Automatically Sign up to receive the latest news and ratings for GH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GH vs. The Competition Export to ExcelMetricGuardant HealthMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$5.83B$2.88B$5.56B$7.83BDividend YieldN/A31.29%5.11%4.22%P/E Ratio-13.2713.2822.4818.48Price / Sales7.89188.21394.56103.59Price / CashN/A57.5638.1834.62Price / Book35.254.676.774.25Net Income-$479.45M-$22.21M$3.22B$248.23M7 Day Performance-0.38%-1.91%1.48%0.89%1 Month Performance11.21%3.24%3.99%3.53%1 Year Performance158.65%11.50%16.15%5.08% Guardant Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GHGuardant Health3.9526 of 5 stars$47.23-4.6%$49.00+3.7%+162.4%$5.83B$739.02M-13.271,790News CoverageGap DownNTRANatera2.8948 of 5 stars$152.99-0.5%$175.76+14.9%+62.5%$20.68B$1.70B-86.933,020Upcoming EarningsInsider TradePositive NewsFMSFresenius Medical Care3.802 of 5 stars$25.05+2.4%$25.30+1.0%+20.6%$14.70B$19.34B20.70123,200Upcoming EarningsPositive NewsHIMSHims & Hers Health3.1885 of 5 stars$28.51+1.5%$38.08+33.6%+164.1%$6.33B$1.48B64.80650Upcoming EarningsAnalyst ForecastInsider TradeOptions VolumeNews CoverageGap DownHigh Trading VolumeOPCHOption Care Health3.155 of 5 stars$32.97+0.2%$33.75+2.4%+8.1%$5.42B$5.00B27.715,600Earnings ReportAnalyst UpgradeNews CoveragePositive NewsRDNTRadNet4.0251 of 5 stars$51.03+1.5%$69.75+36.7%+8.0%$3.78B$1.83B-728.908,970Positive NewsGap DownSHCSotera Health2.3832 of 5 stars$11.26+0.9%$15.20+35.0%+2.7%$3.20B$1.10B45.043,000WGSGeneDx2.2126 of 5 stars$112.49+1.3%$72.33-35.7%+291.6%$3.16B$305.45M-57.391,200News CoveragePositive NewsGap DownBTSGBrightSpring Health Services2.5439 of 5 stars$17.31+2.3%$21.67+25.2%+64.0%$3.03B$11.27B-66.5835,000Upcoming EarningsNews CoveragePositive NewsPRVAPrivia Health Group4.1117 of 5 stars$23.20+0.1%$27.14+17.0%+27.6%$2.81B$1.74B232.02810Upcoming EarningsAnalyst ForecastShort Interest ↓Positive NewsCONConcentra Group Holdings ParentN/A$21.64+1.8%$28.50+31.7%N/A$2.76B$1.90B14.3311,000Upcoming EarningsPositive News Related Companies and Tools Related Companies Natera Alternatives Fresenius Medical Care Alternatives Hims & Hers Health Alternatives Option Care Health Alternatives RadNet Alternatives Sotera Health Alternatives GeneDx Alternatives BrightSpring Health Services Alternatives Privia Health Group Alternatives Concentra Group Holdings Parent Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:GH) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredThe next market Nvidia is positioned to dominate …Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...Weiss Ratings | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredThey rigged the gameThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Guardant Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Guardant Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.